{"entity":{"type":"insider","cik":"0001457518","url":"/insider/0001457518","json_url":"/insider/0001457518.json","name":"First Eagle Value in Biotechnology Master Fund, Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":22,"first":"2010-06-22","last":"2019-06-24","span_basis":"filed_date"},"name_variants":[{"name":"First Eagle Value in Biotechnology Master Fund, Ltd.","source":"filing","n_filings":22,"first_seen":"2010-06-22","last_seen":"2019-06-24"}],"transactions":[{"id":7903755,"accession":"0001567619-19-013856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-013856","line_url":"/filing/0001567619-19-013856#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; 21 APRIL FUND, L.P.; First Eagle Holdings, Inc.","owner_display_name":"First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000000.0,"shares_display":"4,000,000","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":2080000.0,"total_display":"2,080,000.00","total_whole":"2,080,000","shares_owned_after":26476546.0,"shares_owned_after_display":"26,476,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider"},{"id":6444468,"accession":"0001140361-18-008694","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14791.0,"shares_display":"14,791","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":92443.75,"total_display":"92,443.75","total_whole":"92,444","shares_owned_after":4396477.0,"shares_owned_after_display":"4,396,477","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-15","scope":"insider"},{"id":6444465,"accession":"0001140361-18-008694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":40625.0,"total_display":"40,625.00","total_whole":"40,625","shares_owned_after":4381686.0,"shares_owned_after_display":"4,381,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-14","filed_date":"2018-02-15","scope":"insider"},{"id":6444461,"accession":"0001140361-18-008694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-008694","line_url":"/filing/0001140361-18-008694#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":13125.0,"total_display":"13,125.00","total_whole":"13,125","shares_owned_after":4375186.0,"shares_owned_after_display":"4,375,186","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-13","filed_date":"2018-02-15","scope":"insider"},{"id":6065690,"accession":"0001140361-18-006973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-006973","line_url":"/filing/0001140361-18-006973#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12672.0,"shares_display":"12,672","price_per_share":6.2175,"price_display":"6.22","price_state":"stated","total_value":78788.16,"total_display":"78,788.16","total_whole":"78,788","shares_owned_after":4373086.0,"shares_owned_after_display":"4,373,086","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-13","scope":"insider"},{"id":6065686,"accession":"0001140361-18-006973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-006973","line_url":"/filing/0001140361-18-006973#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22600.0,"shares_display":"22,600","price_per_share":6.2051,"price_display":"6.21","price_state":"stated","total_value":140235.26,"total_display":"140,235.26","total_whole":"140,235","shares_owned_after":4360414.0,"shares_owned_after_display":"4,360,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-02-13","scope":"insider"},{"id":6627477,"accession":"0001140361-18-006264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-006264","line_url":"/filing/0001140361-18-006264#line-2","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":6.3192,"price_display":"6.32","price_state":"stated","total_value":110586.0,"total_display":"110,586.00","total_whole":"110,586","shares_owned_after":4337814.0,"shares_owned_after_display":"4,337,814","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-09","scope":"insider"},{"id":6627472,"accession":"0001140361-18-006264","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-006264","line_url":"/filing/0001140361-18-006264#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":6.348,"price_display":"6.35","price_state":"stated","total_value":24122.4,"total_display":"24,122.40","total_whole":"24,122","shares_owned_after":4320314.0,"shares_owned_after_display":"4,320,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-07","filed_date":"2018-02-09","scope":"insider"},{"id":6374395,"accession":"0001140361-18-005487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-005487","line_url":"/filing/0001140361-18-005487#line-3","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45834.0,"shares_display":"45,834","price_per_share":6.328,"price_display":"6.33","price_state":"stated","total_value":290037.552,"total_display":"290,037.55","total_whole":"290,038","shares_owned_after":4316514.0,"shares_owned_after_display":"4,316,514","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-06","filed_date":"2018-02-07","scope":"insider"},{"id":6374391,"accession":"0001140361-18-005487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-005487","line_url":"/filing/0001140361-18-005487","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40498.0,"shares_display":"40,498","price_per_share":6.325525922267766,"price_display":"6.33","price_state":"stated","total_value":256171.1488,"total_display":"256,171.15","total_whole":"256,171","shares_owned_after":4265680.0,"shares_owned_after_display":"4,265,680","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider","n_lines":2},{"id":6576831,"accession":"0001140361-18-004930","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-004930","line_url":"/filing/0001140361-18-004930","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45508.0,"shares_display":"45,508","price_per_share":6.562969543816472,"price_display":"6.56","price_state":"stated","total_value":298667.618,"total_display":"298,667.62","total_whole":"298,668","shares_owned_after":4219882.0,"shares_owned_after_display":"4,219,882","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider","n_lines":2},{"id":6576823,"accession":"0001140361-18-004930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-004930","line_url":"/filing/0001140361-18-004930#line-1","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":6.475,"price_display":"6.48","price_state":"stated","total_value":2590.0,"total_display":"2,590.00","total_whole":"2,590","shares_owned_after":4184674.0,"shares_owned_after_display":"4,184,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":6265845,"accession":"0001140361-18-004372","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61485.0,"shares_display":"61,485","price_per_share":6.830490607465236,"price_display":"6.83","price_state":"stated","total_value":419972.715,"total_display":"419,972.72","total_whole":"419,973","shares_owned_after":4477920.0,"shares_owned_after_display":"4,477,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-31","filed_date":"2018-02-01","scope":"insider","n_lines":2},{"id":6265834,"accession":"0001140361-18-004372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-004372","line_url":"/filing/0001140361-18-004372","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26698.0,"shares_display":"26,698","price_per_share":6.766872926810997,"price_display":"6.77","price_state":"stated","total_value":180661.9734,"total_display":"180,661.97","total_whole":"180,662","shares_owned_after":4416435.0,"shares_owned_after_display":"4,416,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider","n_lines":2},{"id":5179058,"accession":"0001140361-17-019221","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32580.0,"shares_display":"32,580","price_per_share":13.0434,"price_display":"13.04","price_state":"stated","total_value":424953.972,"total_display":"424,953.97","total_whole":"424,954","shares_owned_after":4389737.0,"shares_owned_after_display":"4,389,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-10","scope":"insider","n_lines":2},{"id":5179047,"accession":"0001140361-17-019221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-019221","line_url":"/filing/0001140361-17-019221","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34974.0,"shares_display":"34,974","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":454662.0,"total_display":"454,662.00","total_whole":"454,662","shares_owned_after":4422317.0,"shares_owned_after_display":"4,422,317","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-08","filed_date":"2017-05-10","scope":"insider","n_lines":2},{"id":4787858,"accession":"0001140361-17-018386","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":74100.0,"total_display":"74,100.00","total_whole":"74,100","shares_owned_after":4457291.0,"shares_owned_after_display":"4,457,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-04","scope":"insider","n_lines":2},{"id":4787852,"accession":"0001140361-17-018386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-018386","line_url":"/filing/0001140361-17-018386","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Investment Management, LLC; 21 APRIL FUND, LTD.; First Eagle Holdings, Inc.","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31487.0,"shares_display":"31,487","price_per_share":13.3262,"price_display":"13.33","price_state":"stated","total_value":419602.0594,"total_display":"419,602.06","total_whole":"419,602","shares_owned_after":4462991.0,"shares_owned_after_display":"4,462,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-04","scope":"insider","n_lines":2},{"id":4947439,"accession":"0001140361-17-017790","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30131.0,"shares_display":"30,131","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":391703.0,"total_display":"391,703.00","total_whole":"391,703","shares_owned_after":4494478.0,"shares_owned_after_display":"4,494,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider","n_lines":2},{"id":4947427,"accession":"0001140361-17-017790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-017790","line_url":"/filing/0001140361-17-017790","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":13.0169,"price_display":"13.02","price_state":"stated","total_value":40352.39,"total_display":"40,352.39","total_whole":"40,352","shares_owned_after":4524609.0,"shares_owned_after_display":"4,524,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-28","filed_date":"2017-05-02","scope":"insider","n_lines":2},{"id":5246137,"accession":"0001140361-17-017253","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53185.0,"shares_display":"53,185","price_per_share":13.0087,"price_display":"13.01","price_state":"stated","total_value":691867.7095,"total_display":"691,867.71","total_whole":"691,868","shares_owned_after":4527709.0,"shares_owned_after_display":"4,527,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-28","scope":"insider","n_lines":2},{"id":5246129,"accession":"0001140361-17-017253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-017253","line_url":"/filing/0001140361-17-017253","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"21 APRIL FUND, LTD.; First Eagle Holdings, Inc.; First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_display_name":"21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63630.0,"shares_display":"63,630","price_per_share":13.0261,"price_display":"13.03","price_state":"stated","total_value":828850.743,"total_display":"828,850.74","total_whole":"828,851","shares_owned_after":4580894.0,"shares_owned_after_display":"4,580,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-28","scope":"insider","n_lines":2},{"id":5140679,"accession":"0001140361-17-016840","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-016840","line_url":"/filing/0001140361-17-016840","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246760.0,"shares_display":"246,760","price_per_share":13.340374323229048,"price_display":"13.34","price_state":"stated","total_value":3291870.768,"total_display":"3,291,870.77","total_whole":"3,291,871","shares_owned_after":4644524.0,"shares_owned_after_display":"4,644,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-26","scope":"insider","n_lines":4},{"id":5140655,"accession":"0001140361-17-016840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-016840","line_url":"/filing/0001140361-17-016840","is_derivative":false,"issuer_cik":"0001001902","issuer_name":"INTEVAC INC","issuer_ticker":"IVAC","issuer_name_source":null,"issuer_url":"/issuer/0001001902","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.; 21 APRIL FUND, LTD.; First Eagle Investment Management, LLC","owner_display_name":"First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92097.0,"shares_display":"92,097","price_per_share":13.695997211635557,"price_display":"13.70","price_state":"stated","total_value":1261360.2552,"total_display":"1,261,360.26","total_whole":"1,261,360","shares_owned_after":4901284.0,"shares_owned_after_display":"4,901,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-26","scope":"insider","n_lines":2},{"id":2386630,"accession":"0001140361-16-084885","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-084885","line_url":"/filing/0001140361-16-084885","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, L.P.; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.","owner_display_name":"First Eagle Investment Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":95000.0,"shares_display":"95,000","price_per_share":1.1610263157894738,"price_display":"1.16","price_state":"stated","total_value":110297.5,"total_display":"110,297.50","total_whole":"110,298","shares_owned_after":22431546.0,"shares_owned_after_display":"22,431,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-03","filed_date":"2016-11-04","scope":"insider","n_lines":3},{"id":2171962,"accession":"0001140361-16-080886","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-080886","line_url":"/filing/0001140361-16-080886","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND, L.P.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.","owner_display_name":"21 APRIL FUND, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500000.0,"shares_display":"2,500,000","price_per_share":1.151549376,"price_display":"1.15","price_state":"stated","total_value":2878873.44,"total_display":"2,878,873.44","total_whole":"2,878,873","shares_owned_after":21862770.0,"shares_owned_after_display":"21,862,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider","n_lines":3},{"id":2887726,"accession":"0001140361-16-062146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-062146","line_url":"/filing/0001140361-16-062146#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; 21 APRIL FUND, L.P.","owner_display_name":"First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500000.0,"shares_display":"5,500,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":6875000.0,"total_display":"6,875,000.00","total_whole":"6,875,000","shares_owned_after":19881546.0,"shares_owned_after_display":"19,881,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-26","filed_date":"2016-04-27","scope":"insider"},{"id":2742495,"accession":"0001140361-16-047642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-047642","line_url":"/filing/0001140361-16-047642#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_display_name":"21 APRIL FUND LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300100.0,"shares_display":"300,100","price_per_share":1.368,"price_display":"1.37","price_state":"stated","total_value":410536.8,"total_display":"410,536.80","total_whole":"410,537","shares_owned_after":14381546.0,"shares_owned_after_display":"14,381,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-12","scope":"insider"},{"id":8150131,"accession":"0001140361-15-036416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-036416","line_url":"/filing/0001140361-15-036416#line-2","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LP; 21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; Arnhold & S. Bleichroeder Holdings, Inc.","owner_display_name":"21 APRIL FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":885049.0,"shares_display":"885,049","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":1593088.2,"total_display":"1,593,088.20","total_whole":"1,593,088","shares_owned_after":14081446.0,"shares_owned_after_display":"14,081,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-29","filed_date":"2015-10-01","scope":"insider"},{"id":8150123,"accession":"0001140361-15-036416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-036416","line_url":"/filing/0001140361-15-036416#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LP; 21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; Arnhold & S. Bleichroeder Holdings, Inc.","owner_display_name":"21 APRIL FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67200.0,"shares_display":"67,200","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":106848.0,"total_display":"106,848.00","total_whole":"106,848","shares_owned_after":13196397.0,"shares_owned_after_display":"13,196,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-10-01","scope":"insider"}],"collapsed":true,"next_cursor":"2015-03-17|8150123","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001082038","name":"DURECT CORP","url":"/issuer/0001082038","role":"Ten percent owner","n_filings":7,"first_seen":"2015-03-20","last_seen":"2019-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001001902","name":"INTEVAC INC","url":"/issuer/0001001902","role":"Ten percent owner","n_filings":11,"first_seen":"2017-04-26","last_seen":"2018-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001013238","name":"ARADIGM CORP","url":"/issuer/0001013238","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2010-06-22","last_seen":"2013-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001457518","retrieved_at":"2026-08-23T11:29:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}